C. Hauck, E. Cober, S. S. Richter, F. Perez, R. A. Salata, R. C

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France D.

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis E.V. Lemos, F.P. de la Hoz,

I.J. Schalk Clinical Microbiology and Infection

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections D. Ben-David, R. Kordevani, N. Keller, I. Tal, A. Marzel, O. Gal-Mor, Y.

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit.

Vector control: a cornerstone in the malaria elimination campaign

Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance D. van Duin, E.D. Cober, S.S. Richter,

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

G. Höffken Clinical Microbiology and Infection

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T

New diagnostic tools in schistosomiasis

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J

Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Previously unknown species of Aspergillus

Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia E.V. Lemos, F.P.

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

T.M. File Clinical Microbiology and Infection

Long-term mortality following bloodstream infection

Systematic review of antibiotic consumption in acute care hospitals

Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia S. Terraneo, M. Ferrer, I. Martín-Loeches,

M. Daudin, P. Tattevin, B. Lelong, E. Flecher, S. Lavoué, C. Piau, A

Vaccinations against respiratory tract infections at Hajj

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Virology: a scientific discipline facing new challenges

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections C. Hauck, E. Cober, S.S. Richter, F. Perez, R.A. Salata, R.C. Kalayjian, R.R. Watkins, N.M. Scalera, Y. Doi, K.S. Kaye, S. Evans, V.G. Fowler, R.A. Bonomo, D. van Duin Clinical Microbiology and Infection Volume 22, Issue 6, Pages 513-519 (June 2016) DOI: 10.1016/j.cmi.2016.01.023 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Time-to-hospital-mortality compared between patients infected or colonized with carbapenem-resistant Klebsiella pneumoniae (CRKp). Kaplan–Meier curves are shown and groups were compared using log-rank testing. Data were censored at the time of hospital discharge. (a) Time-to-hospital-mortality in patients with CRKp bloodstream infection. (b) Time-to-hospital-mortality in patients with CRKp pneumonia. (c) Time-to-hospital-mortality in patients with CRKp urinary tract infection. Clinical Microbiology and Infection 2016 22, 513-519DOI: (10.1016/j.cmi.2016.01.023) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions